Learning objective

Understand what patient populations are reflected by the ECLS SHOCK trial, what the trial tells us about the use of VA-ECMO in general and how we should implement the study's findings in our clinical care for patients with cardiogenic shock.

The neutral ECLS SHOCK trial had major implications for the care of patients with acute myocardial infarction and cardiogenic shock, but do the results really apply to all patients and what do they tell us about the use of VA-ECMO in general?

Prof. Steffen Desch and Prof. Alain Combes, two experts in the field, will provide answers during an in-depth discussion of the trial.

More episodes available here